Related Experiment Videos
[Improving perioperative management of oral anticoagulants in 2007]
Charles Marc Samama1, Annick Steib
1Service d'anesthésie-réanimation, Hôtel-Dieu de Paris (75), Paris Cedex 04, France. marc.samama@htd.aphp.fr
Abstract:
Preoperative interruption of oral anticoagulants is not essential for every procedure performed during surgery or outside of the operating room. The thrombotic risk associated with preoperative treatment interruption is too often overestimated. In practice, only patients at elevated risk should receive bridge therapy with standard or low-molecular-weight heparin. Patients with an INR less than 2 can undergo numerous surgical procedures. In the case of an immediate emergency in a patient treated with oral anticoagulants, perfusion with prothrombin complex is recommended. It is very effective and entails few risks. Vitamin K must be used as a complement, or alone in less urgent case, at a low-dose (< 5 mg) and preferably orally. The phase of treatment resumption with a postoperative double treatment of heparin and oral anticoagulants must last long enough to avoid any thrombosis.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis IV: Nursing Management
Aneurysm IV: Nursing Management
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...